Viridans streptococci can kill methicillin-resistant Staphylococcus aureus
or augmentation of the bactericidal activity of H 2 O 2 in oral viridans streptococci is necessary for killing of MRSA.
Coaggregation between MRSA and viridans streptococci may compensate for the inadequate amount of H 2 O 2 . Secretory IgA (SIgA) is the most abundant immunoglobulin produced against both commensal microorganisms [3] and pathogens [4] , even in the saliva of preterm infants [5, 6] . In addition to the 4 Fab binding sites [7, 8] , glycan epitopes on the heavy chains and the secretory component provide SIgA with further bacteria-binding sites and possibly contribute to the formation of coaggregates.
Salivary peroxidase [9, 10] and bacterial catalase [11] may decompose the H 2 O 2 produced by viridans streptococci into harmless final products. It has been suggested that, during its decomposition of H 2 O 2 , salivary peroxidase produces singlet molecular oxygen ( a short-lived by-product [12] . If so, we would hypothesize that 1 O 2 is converted to ozone by the immunoglobulin-catalyzed water-oxidation reaction, as recently described by Wentworth et al. [13, 14] , and that ozone has potent bactericidal activity.
In the present study, we examined the coaggregation between MRSA and viridans streptococci and studied both (1) whether the H 2 O 2 produced by viridans streptococci in saliva is converted to ozone and (2) whether it has bactericidal activity against MRSA and fungicidal activity against Candida albicans.
MATERIALS AND METHODS

Saliva.
Samples of unstimulated whole saliva were obtained from 7 infants and from 5 healthy adult volunteers, by use of a method described elsewhere [15] . All infants were inpatients in the Neonatal Intensive Care Unit of Nagano Children's Hospital, and all were receiving mothers' milk. Before the study, formal permission was obtained from the hospital's ethics com- , catalase-negative Staphylococcus aureus TW 4632, and clinical isolates of Streptococcus sanguinis, C. albicans, and MRSA. These strains were cultured on brain-heart infusion (BHI) broth (Nippon Becton Dickinson). Identification and susceptibility testing were accomplished by use of either MicroScan WalkAway (Dade) or a method described elsewhere [16] .
Depletion of IgA or IgG from saliva. SIgA or secretory IgG was depleted from saliva by repeatedly passing the latter through a monoclonal anti-IgA-coupled (Hytest) or anti-IgGcoupled (Japan Biotest) affinity column (1 mL, HiTrap Nhydroxy-succinimide-activated high performance; Amersham Biosciences), until no residual antibodies were detected by ELISA. The concentration of salivary IgA was determined by use of a commercially available ELISA protein-detector kit (Kirkegaard & Perry Laboratories), according to the manufacturer's instructions.
Aggregation and coaggregation. Viridans streptococci, MRSA (unstained or stained with ethidium bromide), or both were mixed, on a glass slide for several minutes, with either intact saliva, IgA-or IgG-depleted saliva, preadsorbed saliva (saliva adsorbed with MRSA), or colostral SIgA (Cappel), and the aggregates were observed macro-and microscopically. For study of the formation of bacterial aggregates in vivo, oral cavities were swabbed and were stained with May-Grünwald-Giemsa solution.
Flow cytometry. MRSA ( cfu) was incubated, for 30 7 1 ϫ 10 min at room temperature, in either 0.5 mL of 50% saliva in 2-Dimensional gel electrophoresis, and analysis by matrixassisted laser-desorption ionization time-of-flight mass spectrometry (MALDI TOF MS) analysis. Proteins were analyzed according to the method described by Yao et al. [17] . A 2-mL aliquot of Streptococcus sanguinis cell sediments (a result of centrifugation at 1300 g for 30 min at 4ЊC) was incubated, for 60 min at room temperature, with 10 mL of saliva and was washed 3 times with PBS. Salivary components bound to the cell surface were extracted with 4 mol/L NaCl. Streptococcus sanguinis proteins were extracted with a mixture of 8 mol/L urea, 2 mol/L thiourea, and 4% 3-[(cholamidopropyl)dimethylammonio]-1-propane sulfonate [18, 19] . The solvents of these extracted proteins were replaced with either PBS or 8 mol/L urea, by use of a centrifugal filter device (Millipore). Streptococcus sanguinis proteins bound to SIgA were prepared, by use of a colostral SIgA-coupled affinity column. These proteins were analyzed by 2-dimensional gel electrophoresis and MALDI TOF MS (Applied Biosystems). Peptide-mass fingerprints were used to screen tryptic-fragment libraries, by use of Mascot (Matrix Sciences) and Protein Prospector (University of California, San Francisco). All experiments were performed 3 times.
Assay of catalase activity. MRSA or C. albicans (100 mL) was incubated in 2.9 mL of substrate solution (0.1 mL of 30% H 2 O 2 in 50 mL of 0.05 mol/L PBS [pH 7.0]), and the decrease in absorbance at 240 nm at 25ЊC was measured 2 times. One catalase unit was defined as the amount that results in decomposition at a rate of 1.0 mmol of H 2 O 2 /min by cfu, at 8 1 ϫ 10 pH 7.0 and 25ЊC [2] .
Indigo carmine-oxidation reaction, in PBS and in saliva. The method described by Wentworth et al. [14] was used to 
2.5 ϫ 10 1.0 ϫ 10 2.0 ϫ 10 4.0 ϫ 10 1 mL of 1% H 2 O 2 , and 91 mL of either PBS or saliva and was incubated at 37ЊC. At various time points, the decrease in absorbance at 600 nm was measured, 3 times, by use of a microtiter plate reader (Toso). In some experiments, various doses (0.03-300 mU) of either Aspergillus niger catalase (Sigma-Aldrich) or Staphylococcus aureus TW4632 (catalase-negativestrain) were used instead of MRSA. To measure SIgA interference with the reaction, 0, 0.5, or 2.0 mg of human colostral SIgA was added to the reaction mixture comprising indigo carmine, MRSA ( cfu), H 2 O 2 , and PBS. Each experiment was 5 2.5 ϫ 10 performed 5 times.
Assay of 4-vinyl benzoic acid oxidation. The method described by Wentworth et al. [14] was used to measure 4-vinyl benzoic acid oxidation. Saliva (150 mL) was mixed with a solution of 1 mmol/L of 4-vinyl benzoic acid, which reacts with O 3 , in 150 mL of PBS (pH 7.4), 30 mL of 1% H 2 O 2 , and 1.1 mg of human colostral SIgA in 20 mL of PBS and was incubated for 3 h at room temperature. Aliquots (20 mL) were removed and diluted 1:3 in an acetonitrile:water (1:1) mixture. The product composition was determined by reversed-phase high-performance liquid chromatography performed by use of a Jasco LC-800 apparatus (Nihon Bunko) with a Shim-Pack CLC-ODS column. Products were detected by UV light at 254 nm (retention time [RT] for 4-vinyl benzoic acid, 11.47 min; RT for 4-carboxybenzaldehyde, 3.83 min; RT for 4-oxiranyl-benzoic acid, 4.31 min). In the control assay, 4-vinyl benzoic acid was oxidized by irradiation on a transilluminator (312 nm, 0.8 mW/cm 2 ), at room temperature in the presence of SIgA, and the composition of the products was determined by a similar method.
Killing of MRSA by Streptococcus sanguinis. Killing of MRSA by Streptococcus sanguinis was measured by use of 2 small (0.4 cm 3 ) chambers separated by a dialyzing-cellulose membrane (Wako Pure Chemical) made with silicon-rubber sheets, between 2 glass slides. To 1 of these chambers, 4 1 ϫ 10 cfu of MRSA in BHI broth was added; to the other chamber, cfu of Streptococcus sanguinis was added; and both cham- 6 5 ϫ 10 bers were cultured for 16 h at 37ЊC. Cells in each chamber were recovered and were stained with 0.01% acridine orange in PBS for 45 s and then were viewed under a fluorescence microscope [20, 21] . In the control study, the same doses of MRSA were cultured in a similar device but in only 1 chamber. SIgA's augmentation of the killing of MRSA by Streptococcus sanguinis was measured. MRSA (25 mL, 230 cfu) was mixed with various doses (200-3200 cfu) of Streptococcus sanguinis in intact, IgA-or IgGdepleted saliva (125 mL), and the solution was incubated for 4 h at 37ЊC. MRSA viability was measured on the basis of the rate of recovery in the number of colony-forming units in orthophthaldialdehyde/Staphylococcus medium (Nippon Becton Dickinson). These experiments were performed 3 times. Killing of MRSA by Streptococcus sanguinis in 50% salivaagarose plates. MRSA (3 mL, cfu) in PBS was mixed ); at 0.3 mU (line c2), it had no effect; at 300 mU (line c3), it inhibited this activity (for m0 vs. c3, ). D, Staphylococcus aureus (catalase-P ! .003 P ! .001 negative strain TW4632) in saliva, which had no effect on the oxidant-producing activity of salivary peroxidase (line m0), at any of the 3 doses used ( cfu [line a1], cfu [line a2], and cfu [line a3). 2.5 ϫ 10 2.5 ϫ 10 5 ϫ 10 with 9 mL of BHI broth (preincubated for 10 min at 50ЊC) containing 50 mg of low-melting-point agarose (Takara) and 6 mL of saliva, and the solution was poured onto a plastic plate. After the solution solidified, 3.3 mg of colostral SIgA (20 mL) was spotted onto 3 points on the plate and was allowed to soak into the gel, after which , , or cfu of Strep-
1 ϫ 10 1 ϫ 10 1 ϫ 10 tococcus sanguinis (ATCC10556 T ) (10 mL) were each spotted onto 1 of these SIgA-soaked points; the same dose of Streptococcus sanguinis solution, but without SIgA, was similarly spotted onto 3 points on the plate. The plates were cultured overnight at 35ЊC in 5% CO 2 . This experiment was performed 2 times.
Killing of C. albicans by H 2 O 2 in 50% saliva-agarose plates. C. albicans ( cfu) was embedded in saliva/BHI-broth- 8 1 ϫ 10 agarose plates by use of the method described above, and colostral SIgA was soaked into the gel. A. niger catalase (0.3 or 5.0 U) was spotted onto the points soaked with SIgA and onto 2 points not soaked with SIgA. Then, 1% H 2 O 2 (10 mL) was spotted onto the points soaked with SIgA, catalase, or both and onto a point not soaked with either SIgA or catalase. The plate was cultured overnight at 35ЊC in 5% CO 2 . This experiment was performed 2 times.
Statistical analysis. Student's paired t test was used to compare, at the 3 time points (30, 60, and 90 min), differences in either the growth of MRSA cocultured with Streptococcus sanguinis or the absorbance in the indigo carmine-oxidation reaction.
was considered to be significant. P ! .05 Figure 1A shows a representative sample of bacterial aggregate in the oral cavity of an infant. Although the bacterial composition of this aggregate was not determined, similar aggregates were easily formed in vitro by simple agitation of viridans streptococci, either in saliva (figure 1B) or in colostral SIgA (table 1) . However, depletion of IgA ( figure 1C ), but not of IgG, from saliva almost completely abolished aggregation. These data indicate that both SIgA and viridans streptococci are important contributors to bacterial aggregation in vivo. The concentration of IgA in the 7 infants' saliva ( mg/mL) was not significantly dif-33.0 ‫ע‬ 30.4 ferent from that in the 5 adults' saliva ( mg/mL) 78.2 ‫ע‬ 90.2 ( ) (see table 1 ); in contrast, none of the saliva and P p .406 none of the colostral SIgA formed MRSA aggregates, although both saliva from the 5 adults and from 1 infant (infant 1) and colostral SIgA contained anti-MRSA SIgA (figure 2). Coaggregation between MRSA and Streptococcus sanguinis occurred in the saliva of all 5 adults ( figure 3A and 3C ) and in that of 1 infant (infant 4, without anti-MRSA SIgA). The saliva of infant 1 contained anti-MRSA SIgA but did not form coaggregates (see table 1 ). Preadsorption of the 5 adults' saliva with MRSA successfully inhibited coaggregation but not Streptococcus sanguinis aggregation ( figure 3B and 3D) 1.0 ϫ 10 equivalent to the activity with 5.5 mU of catalase]; overall, the comparative oxidant formation in these 3 situations, expressed in terms of the lines in figure 4B, figure 4B, line c) . These data show that, ). For A. niger in saliva, the results were P ! .05 similar: 0.03 mU ( figure 5C, line c1) of A. niger catalase increased the oxidant-producing activity of salivary peroxidase (figure 5C, line m0) ( ), 0.3 mU of this catalase (figure P ! .003 5C, line c2) had no effect on this activity, and 300 mU of this catalase (figure 5C, line c3) inhibited this activity ( ). P ! .001 Staphylococcus aureus (catalase-negative strain TW4632) in saliva had no effect on the oxidant-producing activity of salivary peroxidase, at any of the 3 doses used ( cfu [ figure   5 2.5 ϫ 10 5D, line a1], cfu [ figure 5D , line a2], and cfu 6 6 2.5 ϫ 10 5 ϫ 10 [ figure 5D, line a3) .
RESULTS
Aggregation and coaggregation.
SIgA-mediated interference with the indigo carmine-oxidation reaction. After 180 min, exogenous SIgA (0.5 or 2.0 mg) decreased both the rate of the indigo carmine-oxidation reaction by salivary peroxidase and the rate of the MRSA catalase-catalyzed H 2 O 2 -decomposition reaction, by 11.9% and 28.6% ( ), respectively (data not shown). This result P ! .001 suggests that SIgA mediates the production of an indigo carmine-nonreactive product, presumably the reformation of H 2 O 2 . If so, then the indigo carmine-reactive componentsozone and 1 O 2 -are both products of the reaction. Next, we tried to ascertain whether the reaction products included ozone.
Assay of 4-vinyl benzoic acid oxidation. Ozonolysis of 4-vinyl benzoic acid was measured by reversed-phase high-performance liquid chromatography. In the presence of SIgA and saliva, H 2 O 2 oxidized 4-vinyl benzoic acid (RT, 11.47 min) and produced 4-carboxybenzaldehyde (RT, 3.83 min) and 4-oxiranyl-benzoic acid (RT, 4.31 min), whereas neither H 2 O 2 in PBS nor SIgA and saliva without H 2 O 2 oxidized it; and 4-vinyl benzoic acid was similarly oxidized by ozone produced by UV irradiation (data not shown). These data show that H 2 O 2 is decomposed by saliva and is converted to ozone by the catalytic activity of SIgA.
Killing of MRSA by Streptococcus sanguinis. Staining with acridine orange showed that the effector molecule(s) produced by Streptococcus sanguinis passed through the cellulose membrane and killed MRSA in the neighboring chamber (figure 6A, no fluorescence), whereas Streptococcus sanguinis (figure 6B, orange fluorescence) and MRSA in a single-chamber device (figure 6C) survived. MRSA killed by reagent H 2 O 2 did not emit fluorescence ( figure 6D ). SIgA augmented this bactericidal activity of Streptococcus sanguinis. In the coaggregate (intact saliva), Streptococcus sanguinis decreased the survival rate of MRSA in a dose-dependent manner, compared with the rate when MRSA was incubated alone ( ). Initially, complete P ! .001 killing of 230 cfu of MRSA required 17 times more (у1600 cfu of) Streptococcus sanguinis (figure 7). However, Streptococcus sanguinis decreased the survival rate of MRSA similarly in IgAdepleted saliva; the survival rate of MRSA recovered completely in SIgA-depleted saliva, whereas it did not recover in either intact or IgG-depleted saliva ( 1 ϫ 10 level of killing, we compared the squares of the radii of the clear zones. The addition of 3.3 mg of colostral SIgA, which contained anti-MRSA SIgA (see figure 2) , augmented the killing of MRSA, and larger areas remained clear around Streptococcus sanguinis at cfu, cfu ( ), and cfu 8 7 6 1 ϫ 10 1 ϫ 10 P ! .001 1 ϫ 10 ( ) (table 3A) .
The data in 
DISCUSSION
The data in the present study demonstrate a previously unrecognized process that may help to maintain homeostasis in the oral cavity and thereby defend the oral environment against pathogens. Coaggregation between viridans streptococci and pathogens, in conjunction with the catabolism of H 2 O 2 in the aggregates to produce ozone by SIgA, seems to be the key event in this process. SIgA is responsible for mucosal defense, not only by immune exclusion [22] , but also by direct killing of pathogens.
SIgA contains various bacteria-binding sites in its glycans, in addition to its 4 Fab binding sites [7, 8] , and it binds to bacterial surface proteins, such as fructose bisphosphate aldolase of Streptococcus pneumoniae [23] . In fact, the present study found that SIgA binds to viridans streptococci and forms aggregates. However, such aggregation was not found when MRSA was used, presumably because of the latter's significant z potential (i.e., the electrical potential of the interface between the bacterial surface and the aqueous environment) [24] , a characteristic that is an advantage in the development of an MRSA-killing process: even in the presence of anti-MRSA SIgA, MRSA cells invading the oral cavity may remain unaggregated until they associate with numerous viridans streptococci cells [25] [12, 14] . However, this oxidant is not strong enough to kill some resistant microorganisms, such as C. albicans [2] . In the present study, the addition of SIgA and small doses of A. niger catalase significantly augmented this oxidant's bactericidal and fungicidal effects, and more C. albicans cells were killed by the newly synthesized oxidant. Ozone may be produced by the SIgAcatalyzed water-oxidation reaction [14] . If so, then the oxidant produced before the addition of SIgA is 1 O 2 , one of the starting materials of the reaction [12] , and the products of 4-vinyl benzoic acid oxidation strongly suggest that ozone is present [14] . In this situation, MRSA catalase may potentiate not the survival but, instead, the suicide of MRSA.
None of the viridans streptococci tested in our earlier study were low-H 2 O 2 -producing strains [2] ; and the present study used physiological amounts of SIgA, A. niger catalase, and reagent H 2 O 2 . In the present study, the concentration of SIgA that was soaked into the plates was 5 times greater than that in intact saliva, and this concentration may be achieved by the coaggregation formation even in infants. Similarly, the concentrations of H 2 O 2 and A. niger catalase were equivalent to the amounts produced by cfu of either viridans strep- 8 1 ϫ 10 tococci [25] or MRSA and may be achievable in the oral cavity [2] . Ozone may be toxic to oral epithelia [26] ; however, because it is short lived [14] , tissue damage is limited to a narrow region around the coaggregates. In BHI broth, 1500 viridans streptococci cells are necessary to kill 1 MRSA cell [2] , whereas the results of the present study show that only 7 viridans streptococci cells are necessary to kill each MRSA cell in the coaggregates. Therefore, the killing of MRSA and of C. albicans may actually occur in the oral cavity. Mucosal surfaces other than the oral cavity, such as the vaginal mucosa, which harbors H 2 O 2 -producing lactobacilli, may have a similar system to destroy pathogens [27] .
In conclusion, the results of the present study show that, in cooperation with H 2 O 2 -producing viridans streptococci and salivary components, SIgA can kill MRSA and C. albicans-and that this killing potential is augmented by bacterial catalase.
